Home > Cashflow Statement > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹1,674 Cr₹862 Cr₹202 Cr₹580 Cr₹569 Cr
Adjustment ₹134 Cr₹102 Cr₹124 Cr₹62 Cr₹54 Cr
Changes In working Capital ₹-309 Cr₹63 Cr₹-231 Cr₹-213 Cr₹-98 Cr
Cash Flow after changes in Working Capital ₹1,498 Cr₹1,027 Cr₹95 Cr₹429 Cr₹525 Cr
Cash Flow from Operating Activities ₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr₹417 Cr
Cash Flow from Investing Activities ₹-1,033 Cr₹-477 Cr₹-5.30 Cr₹-103 Cr₹-167 Cr
Cash Flow from Financing Activities ₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr₹-251 Cr
Net Cash Inflow / Outflow ₹-68 Cr₹9.00 Cr₹76 Cr₹9.80 Cr₹-0.50 Cr
Opening Cash & Cash Equivalents ₹132 Cr₹111 Cr₹26 Cr₹20 Cr₹28 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹6.50 Cr₹12 Cr₹9.30 Cr₹-3.80 Cr₹-8.00 Cr
Closing Cash & Cash Equivalent ₹70 Cr₹132 Cr₹111 Cr₹26 Cr₹20 Cr

Compare Cashflow Statement of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,464.4 Cr 0.2% 6.7% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,519.0 Cr 1.6% -2.9% 17.2% Stock Analytics
DIVIS LABORATORIES ₹175,903.0 Cr 1.5% 10.4% 51.9% Stock Analytics
CIPLA ₹121,669.0 Cr 2.3% 1.9% 2.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,097.0 Cr 5.7% 14.1% 15.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,605.0 Cr 1.4% 1.3% 17% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.2%

6.7%

-11.6%

SENSEX

1.3%

2.6%

7.8%


You may also like the below Video Courses